A phase 3b, open-label pilot study to evaluate the safety and effectiveness of up to four treatment cycles of AA4500 in combination with the ErecAid Esteem Manual Vacuum Therapy System in men with Peyronie's disease
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2017
Price : $35 *
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 17 Jun 2016 Status changed from active, no longer recruiting to completed.
- 22 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
- 22 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.